Menu Search
Equities

Captor Therapeutics SA

60Q:FRA

Captor Therapeutics SA

Actions
  • Price (EUR)16.25
  • Today's Change-0.25 / -1.52%
  • Shares traded--
  • 1 Year change-30.56%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in PLNView more

In 2023, Captor Therapeutics SA increased its cash reserves by 6.57%, or 4.67m. Cash Flow from Financing totalled 36.94m or 279.83% of revenues. In addition the company used 52.20m for operations while cash from investing totalled 19.93m.
Cash flow per share-9.16
Price/Cash flow per share--
Book value per share10.87
Tangible book value per share10.59
More ▼

Balance sheet in PLNView more

Captor Therapeutics SA appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio2.82
Quick ratio--
Total debt/total equity0.1253
Total debt/total capital0.1114
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.